Tech Company Financing Transactions
ElMindA Funding Round
Healthcare Angels, OurCrowd and Palisade Capital Management joined a $28 million Series C venture round for ElMindA. The round was announced by the company on 11/18/2015.
Transaction Overview
Company Name
Announced On
11/18/2015
Transaction Type
Venture Equity
Amount
$28,000,000
Round
Series C
Proceeds Purpose
The company intends to use the funds for commercial and clinical adoption of its proprietary BNA� (Brain Network Activation) system.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1205 Milwaukee Ave. 202
Glenview, IL 60025
USA
Glenview, IL 60025
USA
Phone
Website
Email Address
Not Recorded
Overview
Our vision is to bring a paradigm change to the management of brain disorders and injuries, by transforming state of the art neuroscience into bed-side clinical practice. BNA is cleared by the FDA for marketing in the US.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ronen Gadot
Chief Financial Officer
Geri Katz
Chief Technical Officer
Amir Geva
Vice President
Tanya Bokobza
Vice President
Ziv Peremen
VP - Human Resources
Chen Golan
Browse more venture capital transactions:
Prev: 11/17/2015: Huuuge venture capital transaction
Next: 11/18/2015: Athos venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs